imiquimod has been researched along with Atherogenesis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cardoso, RM; Hansen, PR; Madsen, M; Nielsen, LB; Pedersen, TX; van Eck, M | 1 |
| Chan, ZW; Chui, LG; Feingold, KR; Grunfeld, C; Kazemi, MR; Londos, C; Magra, AL; McDonald, CM; Patzek, SM; Shigenaga, JK | 1 |
2 other study(ies) available for imiquimod and Atherogenesis
| Article | Year |
|---|---|
Imiquimod-Induced Psoriasis-Like Skin Lesions Do Not Accelerate Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient Mice.
Topics: Animals; Atherosclerosis; Disease Models, Animal; Female; Imiquimod; Mice; Mice, Knockout; Psoriasis; Receptors, LDL; Skin Diseases | 2018 |
ADRP/ADFP and Mal1 expression are increased in macrophages treated with TLR agonists.
Topics: Aminoquinolines; Animals; Atherosclerosis; Cholesterol Esters; Fatty Acid-Binding Proteins; Humans; Imiquimod; Lipopolysaccharides; Macrophage Activation; Macrophages; Membrane Proteins; Mice; Neoplasm Proteins; Perilipin-2; Poly I-C; Toll-Like Receptors; Triglycerides; Zymosan | 2010 |